Supply Chain/Technology

Latest Issue of OR Manager
April 2023
Home Supply Chain/Technology

FDA: Class I recall of Arrow AutoCAT2, AC3 IABPs

Editor's Note The Food and Drug Administration (FDA), on December 20, identified the recall by Arrow International, LLC, subsidiary of Teleflex, Inc, of its Arrow AutoCAT 2 and AC3 intra-aortic balloon pumps (IABPs) as Class I, the most serious. IABPs are used in patients having cardiac and non-cardiac surgery, and…

Read More

By: Judy Mathias
January 3, 2023
Share

Deloitte surveys 2023 outlook for healthcare systems, plans

Editor's Note Hospital leaders are preparing for what is expected to be a turbulent 2023, according to results of a December 13 survey from the Deloitte Center for Health Solutions, reports December 19 Healthcare Purchasing News. The majority of health system leaders said that staffing challenges (85%) and inflation (76%)…

Read More

By: Bridget Brown
December 29, 2022
Share

State of natural language processing in surgery: Part 2

Takeaways Natural language processing (NLP) may be helpful for predicting surgical outcomes and can facilitate more robust research. NLP comes with challenges that include potential for bias, costs, technology and terminology barriers, and the need to adapt to new ways of thinking. Before purchasing products that use NLP, OR leaders…

Read More

By: Cynthia Saver, MS, RN
December 15, 2022
Share

Sponsored Message

New AMDR report strengthens case for single-use medical device reprocessing

Recent analysis provided by the Association of Medical Device Reprocessors (AMDR) indicates that US hospitals could save up to $2.28 billion a year by maximizing the use of reprocessed single-use medical devices. According to the report, in 2020, US hospitals saved $372 million just by reprocessing single-use medical devices, as…

Read More

By: Jake Colletti
December 15, 2022
Share

Key lessons on supply management at OR Manager Conference

Two major challenges that perioperative leaders are facing today are labor and supply costs. These two areas also happen to be the largest and second largest expense categories at most hospitals, making the challenges even more pronounced. What actions can leaders put in place to ensure that clinical staff are…

Read More

By: Vicky Lyle
December 15, 2022
Share

Tackling internal objections to single-use device reprocessing

Many healthcare professionals are aware of single-use device reprocessing and its benefits. According to the Association of Medical Device Reprocessors, the savings generated by such programs can strengthen a facility’s financial sustainability and help provide a path for more responsible environmental stewardship. Sometimes, ambulatory surgery centers (ASCs) may experience situations…

Read More

By: Ken Diebner and Scott Jackson
December 15, 2022
Share

Sponsored Message

FDA: Exela Pharma Sciences, LLC, expands recall of Sodium Bicarb

Editor's Note The Food and Drug Administration (FDA) on November 29 posted Exela Pharma Sciences’ expansion of its recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. The product poses a safety concern because of vial breakage with flying glass when pressurized while preparing the product for…

Read More

By: Judy Mathias
December 12, 2022
Share

Intervention reduces waste from single-use surgical packs

Editor's Note This study by researchers at Harbor-UCLA Medical Center, Torrance, California, finds that simple adjustments to single-use surgical packs can have a significant impact on waste reduction and cost-savings in general surgery cases. Researchers tracked unused items in two standard packs opened for 35 general surgery cases. A new…

Read More

By: Judy Mathias
December 8, 2022
Share

FDA: Class I recall of Baxter Hillrom WatchCare IMS for RF interference risk

Editor's Note The Food and Drug Administration, on November 23, identified the recall by Baxter Hillrom of its WatchCare Incontinence Management System (IMS) as Class I, the most serious. The recall was initiated because of the risk for radiofrequency (RF) emissions from WatchCare devices that may interfere with other devices,…

Read More

By: Judy Mathias
November 29, 2022
Share

FDA: Class I recall of Insulet Omnipod DASH PDM

Editor's Note The Food and Drug Administration (FDA) on November 16 identified the recall by Insulet of its Omnipod DASH Insulin Management System Personal Diabetes Manager (PDM) as Class I, the most serious. The recall was initiated because of PDM battery issues, including: Battery swelling Fluid leakage from the battery…

Read More

By: Judy Mathias
November 17, 2022
Share
Live chat by BoldChat